Which does not cause malignant hyperthermia –
Hypothermia is used in all except:
A patient aged 24 years is said to have 'severe hypothermia' requiring intensive care management, if his core body temperature is-
Shivering observed in the early part of the postoperative period is due to
Malignant hyperthermia is due to
Adverse effects of hypothermia are all except:
A 72-year-old man undergoes resection of an abdominal aneurysm. He arrives in the ICU with a core temperature of 33°C (91.4°F) and shivering. Which of the following is a physiologic consequence of the shivering?
Artery cannulated most commonly for invasive blood pressure monitoring is:
About diagnosing air embolism with transesophageal echocardiography, which of the following is false?
Which of the following anesthetic agents does not trigger malignant hyperthermia?
Explanation: ***N2O*** - **Nitrous oxide** is a weak inhaled anesthetic and does not trigger **malignant hyperthermia** (MH). - Its mechanism of action does not involve the **ryanodine receptor** or calcium release, which are central to MH pathophysiology. *Enflurane* - **Enflurane** is a volatile inhaled anesthetic that is a known trigger for **malignant hyperthermia**. - It induces uncontrolled **intracellular calcium release** in skeletal muscle, leading to hypermetabolism. *Desflurane* - **Desflurane** is another potent volatile inhaled anesthetic and a classic trigger agent for **malignant hyperthermia**. - Its use can result in a rapid onset of MH symptoms due to its quick pharmacokinetics. *Isoflurane* - **Isoflurane** is also a volatile inhaled anesthetic and is well-established as a trigger for **malignant hyperthermia**. - Like other volatile agents, it can bind to the **ryanodine receptor** (RyR1), causing excessive calcium efflux.
Explanation: ***Arrhythmia*** - While sometimes used in specific cardiac procedures or to protect organs during cardioplegia, **therapeutic hypothermia** is not a primary treatment for general cardiac arrhythmias due to its potential to exacerbate certain rhythm disturbances. - **Hypothermia** can paradoxically induce **arrhythmias** itself, particularly bradycardia and ventricular fibrillation, making it unsuitable for general arrhythmia management [1]. *Hyperthermia* - **Therapeutic hypothermia** is used to reduce high body temperatures in conditions like **malignant hyperthermia** and **heatstroke** to prevent organ damage [2]. - By actively cooling the body, hypothermia counteracts the harmful effects of sustained, extreme elevations in body temperature. *Neonatal asphyxia* - **Therapeutic hypothermia** is a standard treatment for **neonatal hypoxic-ischemic encephalopathy** (HIE) to reduce brain injury. - Cooling the infant's body temperature helps to slow down damaging metabolic processes after oxygen deprivation. *Cardiac surgery* - **Hypothermia** is commonly employed during **cardiac surgery** to protect organs, especially the brain and heart, from ischemia during periods of reduced blood flow. - **Moderate to deep hypothermia** can significantly reduce metabolic demands, extending the safe duration of cardiopulmonary bypass and aortic cross-clamping [3].
Explanation: ***<28degC*** - Core body temperatures falling below **28°C** are classified as severe hypothermia, as per most clinical guidelines [1], [2]. - This level of hypothermia requires **intensive care management** due to the high risk of severe complications like **cardiac arrhythmias**, especially **ventricular fibrillation** [2]. *<25degC* - While a core temperature of less than **25°C** is certainly a critical medical emergency, it falls under the category of **profound hypothermia**, which is even more severe than general severe hypothermia. - At this temperature, the risk of **cardiac arrest** and multi-organ failure is exceptionally high, and it represents an extreme rather than the general threshold for severe. *<32degC* - A core body temperature between **28°C and 32°C** is classified as **moderate hypothermia** [2]. - While requiring medical attention and monitoring, it is generally not deemed "severe" enough to immediately necessitate the same level of intensive critical care intervention as temperatures below 28°C. *<35degC* - A core body temperature between **32°C and 35°C** is classified as **mild hypothermia**. - At this stage, the body's compensatory mechanisms are often still active, and initial management typically involves passive or active external rewarming, without immediate intensive care.
Explanation: **Hypothermia** - Shivering is a primary physiological response to **hypothermia**, an attempt by the body to generate **heat** by increasing muscle activity. - Patients often experience a drop in core body temperature during surgery due to factors like cold operating rooms, exposed body cavities, and anesthetic effects. *Pain* - While pain can cause discomfort and muscle tension, it typically does not manifest as generalized **shivering** in the early postoperative period. - Pain is usually managed with analgesics, and shivering is more indicative of a **thermoregulatory disturbance**. *Emergence delirium* - Emergence delirium is characterized by disorientation, agitation, and non-purposeful movements, but not primarily by **shivering**. - This condition is often related to the residual effects of anesthetic agents or anxiety upon waking. *Drug withdrawal* - Drug withdrawal can cause tremors and agitation, but it is less likely to present as **shivering** in the immediate postoperative period in a patient without a known history of substance dependence. - Withdrawal symptoms typically manifest hours to days after the cessation of the drug, depending on its half-life.
Explanation: ***All of the options*** - Malignant hyperthermia is a rare, **life-threatening condition** triggered by exposure to certain anesthetic agents, including **volatile inhalational anesthetics** (like isoflurane and halothane) and the **depolarizing muscle relaxant succinylcholine (scoline)**. - The condition is characterized by a rapid, uncontrollable increase in body temperature, muscle rigidity, and metabolic acidosis due to an uncontrolled release of **calcium** from the sarcoplasmic reticulum in muscle cells. *Isoflurane* - **Isoflurane** is a **volatile inhalational anesthetic** known to be a potent trigger for malignant hyperthermia in susceptible individuals. - It works by affecting ion channels in nerve cells, but in MH-susceptible individuals, it can induce massive calcium release in skeletal muscle. *Halothane* - **Halothane**, another **volatile inhalational anesthetic**, was historically one of the most common triggers for malignant hyperthermia. - While it is less commonly used today due to its potential for liver toxicity and cardiac arrhythmias, it remains a significant trigger for MH. *Scoline* - **Scoline** (also known as **succinylcholine**) is a **depolarizing muscle relaxant** and is a well-known trigger for malignant hyperthermia. - It acts on acetylcholine receptors, causing initial muscle fasciculations followed by prolonged relaxation, but in MH-susceptible patients, it can initiate an uncontrolled calcium release in muscle cells.
Explanation: ***Decreased peripheral resistance*** - Hypothermia causes **vasoconstriction** in the periphery, which leads to **increased peripheral resistance**, not decreased. - This effect helps redirect blood flow to vital organs during cold exposure. *Cardiac arrhythmias* - Hypothermia significantly increases the risk of **cardiac arrhythmias**, especially **ventricular fibrillation**, as myocardial excitability changes [1]. - The most common ECG changes include a **prolonged PR interval**, **widened QRS complex**, and the presence of **J (Osborn) waves** [2]. *Renal failure* - Severe hypothermia can lead to **acute kidney injury** or **renal failure** due to reduced renal blood flow, direct cellular damage, and rhabdomyolysis [1], [3]. - Decreased kidney function can also impair the excretion of drugs and metabolic waste products. *Reversible coagulopathy* - Hypothermia causes a **reversible coagulopathy** due to impaired platelet function, decreased activity of coagulation factors, and increased fibrinolysis. - This can manifest as increased bleeding tendencies, particularly in trauma patients.
Explanation: ***Increased production of CO2*** - Shivering is a physiological response to **hypothermia** that involves rapid, involuntary muscle contractions. - This muscle activity significantly increases **metabolic rate**, leading to higher oxygen consumption and consequently, increased **carbon dioxide production**. *Rising mixed venous O2 saturation* - Shivering increases tissue oxygen demand, therefore, the peripheral tissues extract more oxygen from the blood. - This increased extraction would lead to a *decrease* in mixed venous O2 saturation, as less oxygen returns to the heart. *Rising base excess* - Increased metabolic activity from shivering can lead to the production of **lactic acid** if oxygen demand outstrips supply (anaerobic metabolism). - This would result in **metabolic acidosis**, which is characterized by a *negative* base excess (or decreasing base excess), not a rising one. *Decreased consumption of O2* - Shivering is an active process that requires energy, and this energy is primarily generated through **aerobic metabolism** in the muscles. - Therefore, shivering leads to a significant *increase* in oxygen consumption, not a decrease.
Explanation: ***Radial artery*** - The **radial artery** is the most common site due to its **superficial location**, ease of access, and presence of collateral circulation via the **ulnar artery** (Allen's test). - This allows for safe cannulation with a low risk of **ischemia** to the hand, even if the radial artery becomes thrombosed. *Femoral artery* - The **femoral artery** is used, especially in emergencies or when radial access is not possible, but it carries a higher risk of **infection** and hematoma. - Its deep location can make cannulation more challenging, and complications like **retroperitoneal hemorrhage** are possible. *Ulnar artery* - The **ulnar artery** is generally avoided for primary arterial cannulation because the radial artery is the more dominant blood supply to the hand. - Cannulating the ulnar artery carries a higher risk of **ischemia** to the hand if an anatomical anomaly exists or if the radial artery's collateral flow is compromised. *Carotid artery* - The **carotid artery** is rarely, if ever, cannulated for routine invasive blood pressure monitoring due to the significant risk of **neurological complications** such as stroke or cerebral embolism. - This artery supplies blood directly to the brain, and any damage or clot formation during cannulation could have devastating consequences.
Explanation: ***Interferes with Doppler when used together.*** - Transesophageal echocardiography (TEE) is often used in conjunction with **Doppler ultrasonography** to assess blood flow and cardiac function simultaneously, without significant interference. - **Doppler** can help detect turbulent flow caused by air emboli, while TEE provides direct visualization of the heart chambers and great vessels. *It can quantify the volume of air embolized.* - TEE can visualize air emboli within the cardiac chambers but **cannot accurately quantify the precise volume** of air embolized. - TEE provides qualitative assessment and can estimate the **severity of air emboli** (e.g., small, moderate, large shower), but not a specific volume in milliliters. *It is a very sensitive investigation.* - TEE is indeed a **highly sensitive method** for detecting air emboli, even small amounts, within the heart and major vessels. - Its proximity to the heart allows for **excellent resolution** and clear visualization, making it superior to precordial Doppler for detecting intracardiac air. *Continuous monitoring is needed to detect venous embolism.* - **Venous air emboli** can be intermittent or transient, making continuous TEE monitoring crucial for their detection during high-risk procedures. - Without continuous monitoring, a brief embolic event could be **missed**, as air can quickly pass through the right heart or dissipate.
Explanation: ***Thiopentone*** - **Thiopentone** is an **intravenous anesthetic agent** that does not trigger **malignant hyperthermia** because it does not interact with the **ryanodine receptor (RyR1)** or lead to uncontrolled calcium release from the sarcoplasmic reticulum. - It is a **barbiturate** and its mechanism of action involves enhancing the effect of **GABA** at the GABA-A receptor, unrelated to the calcium dysregulation seen in malignant hyperthermia. *Isoflurane* - **Isoflurane** is a **volatile anesthetic agent** (inhaled) known to be a potent trigger of **malignant hyperthermia** in susceptible individuals. - It directly activates the **ryanodine receptor type 1 (RyR1)**, leading to a massive and uncontrolled release of calcium from the **sarcoplasmic reticulum** in skeletal muscle cells. *Suxamethonium* - **Suxamethonium** (succinylcholine) is a **depolarizing neuromuscular blocker** that can trigger or exacerbate **malignant hyperthermia**, especially when given with volatile anesthetics. - It causes muscle fasciculations and can lead to a sustained muscle contraction and metabolic derangements characteristic of the condition. *Halothane* - **Halothane** is a prototype **volatile anesthetic agent** and is one of the most well-known and potent triggers of **malignant hyperthermia**. - Its use has significantly decreased due to its association with malignant hyperthermia and hepatotoxicity, but it serves as a classic example of an agent that causes massive calcium release from the **sarcoplasmic reticulum**.
Get full access to all questions, explanations, and performance tracking.
Start For Free